RESEARCH-USE BIOSIMILAR ANTIBODY
Lomtegovimab
Monoclonal antibody · IgG1
Lomtegovimab (BI 767551) is a human anti-SARS-COV-2 spike glycoprotein monoclonal antibody. Lomtegovimab binds and neutralizes SARS-CoV-2. Lomtegovimab shows antiviral efficacy. Lomtegovimab has the potential for the research of COVID-19.
TARGETSARS-CoV-2 Spike RBD
YMonoclonal antibody
CATALOGSC-BS-416
CATALOG NUMBERSC-BS-416
MOLECULAR WEIGHTApprox. 145.58 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Lomtegovimab (BI 767551) is a human anti-SARS-COV-2 spike glycoprotein monoclonal antibody. Lomtegovimab binds and neutralizes SARS-CoV-2. Lomtegovimab shows antiviral efficacy. Lomtegovimab has the potential for the research of COVID-19.
Lomtegovimab is a recombinant research-use antibody directed against SARS-CoV-2 Spike RBD.